NeoGenomics(CH:NG9)
CH:NG9
NeoGenomics Revenue
NeoGenomics (NG9) Revenue
0 Followers
NeoGenomics Revenue
NeoGenomics had a revenue of 209.25M in the quarter ending Sep 30, 2026, with 3.77%. This bring the company's revenue in the last twelve months to 787.75M, Increased 2.80%. In the fiscal year ending Dec 31, 2025, NeoGenomics had annual revenue of 727.33M with 10.11% growth.
- Revenue (ttm)
- 787.75M
- Revenue Growth
- 4.23%
- P/S Ratio
- 2.49
- Revenue/Employee
- CHF 290,933
- Employees
- 2,500
- Market Cap
- CHF 1.81B
Revenue Chart
NeoGenomics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 727.33M | 66.77M | 10.11% |
| Dec 31, 2024 | 660.57M | 68.92M | 11.65% |
| Dec 31, 2023 | 591.64M | 81.92M | 16.07% |
| Dec 31, 2022 | 509.73M | 25.40M | 5.24% |
| Dec 31, 2021 | 484.33M | 39.88M | 8.97% |
| Dec 31, 2020 | 444.45M | 35.62M | 8.71% |
| Dec 31, 2019 | 408.83M | 132.09M | 47.73% |
| Dec 31, 2018 | 276.74M | 36.49M | 15.19% |
| Dec 31, 2017 | 240.25M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.